Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Gains from Investment Securities (2021 - 2025)

Mereo BioPharma (MREO) has disclosed Gains from Investment Securities for 4 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 659.87% to -$1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.8 million through Dec 2025, down 196.86% year-over-year, with the annual reading at $133506.0 for FY2025, 98.82% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$1.2 million at Mereo BioPharma, down from $13.5 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $13.6 million in Q1 2025, with the low at -$1.2 million in Q4 2025.
  • Average Gains from Investment Securities over 4 years is $3.4 million, with a median of $74644.0 recorded in 2023.
  • Peak annual rise in Gains from Investment Securities hit 57400.56% in 2025, while the deepest fall reached 659.87% in 2025.
  • Over 4 years, Gains from Investment Securities stood at $2.6 million in 2021, then crashed by 134.58% to -$897000.0 in 2023, then soared by 82.5% to -$157000.0 in 2024, then tumbled by 659.87% to -$1.2 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$1.2 million, $13.5 million, and $13.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.